科技赋能慢病管理，方舟云康以AI构建健康科普新生态

Core Insights - The article highlights the transformative opportunities in the internet healthcare industry driven by rapid advancements in artificial intelligence and the implementation of the Healthy China 2030 strategy [1][2][3] Group 1: Company Overview - Fangzhou Yunkang is recognized as a leading "AI + chronic disease management" service platform in China, establishing itself as an industry benchmark through innovative technology applications and a solid service system [1] - The company has developed a comprehensive health science popularization platform, "Fangzhou Yiliao," aimed at shifting patients from passive recognition to active management of their health [1] Group 2: Service and Technology Integration - Fangzhou Yiliao has upgraded its service model to an "AI + H2H" ecosystem, integrating AI technology throughout the health science popularization process [2] - The platform utilizes a self-developed large model to simplify complex pathological mechanisms into easily understandable content, enhancing user accessibility to health knowledge [2] Group 3: Achievements and Recognition - Fangzhou Yunkang has received multiple industry awards, including the "2025 Annual Social Responsibility Golden Bull Award" from China Securities Journal and recognition as a "Demonstration Case of Growth in Hong Kong Stocks" from China Fund News, reflecting strong market confidence in its development model and growth potential [3] - The company aims to continue deepening the integration of "AI + chronic disease management," focusing on delivering high-quality health science content and intelligent management services to enhance public health literacy [3]